A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Casirivimab, Ceftriaxone10

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	325–1000 mg	PO	not captured	standing	page 200
Fever	adult	325–1000 mg	IV/IO	not captured	standing	page 200
Fever	peds	15 mg/kg	PO	not captured	standing	page 200
Fever	peds	15 mg/kg	IV/IO	not captured	standing	page 200
Mild to moderate pain	adult	15 mg/kg	IV/IO	not captured	standing	page 201
Mild to moderate pain	adult	325–1000 mg	PO	not captured	standing	page 201
Mild to moderate pain	peds	15 mg/kg	PO	not captured	standing	page 201

Activated Charcoal

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g/kg	PO	not captured	standing	page 156
Other	peds	1 g/kg	PO	not captured	standing	page 156

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV/IO	not captured	standing	pages 23, 25, 104, 106
Narrow-complex tachycardia	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 23, 25, 104, 106

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	2.5–5 mg	NEB	not captured	standing	pages 49, 115
Allergic reaction	peds	2.5–5 mg	NEB	not captured	standing	pages 49, 115
Asthma / bronchospasm	adult	2.5–5 mg	NEB	not captured	standing	pages 79, 85
Asthma / bronchospasm	peds	1.25–2.5 mg	NEB	not captured	standing	pages 79, 85
Croup	adult	2.5–5 mg	NEB	not captured	standing	pages 79, 85
Croup	peds	1.25–2.5 mg	NEB	not captured	standing	pages 79, 85

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	300 mg	IV/IO	not captured	standing	pages 29, 108
Cardiac arrest	peds	5 mg/kg	IV/IO	not captured	standing	pages 29, 108
Narrow-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 23, 25, 107
Narrow-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	pages 23, 25, 107

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	325 mg	PO	not captured	standing	page 19

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	pages 15, 99
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 15, 99
Nerve agent exposure	adult	2 mg	IV/IO/IM	not captured	standing	page 158

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	pages 53, 167
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	pages 53, 167

Casirivimab

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	600 mg	IV	not captured	standing	page 134
Other	adult	600 mg	SQ	not captured	standing	page 134

Ceftriaxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	2 g	IV/IO	not captured	standing	page 169

D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl, Furosemide10

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	10 mg	IV/IO/IM	not captured	standing	pages 57, 120
Adrenal crisis	peds	5 mg	IV/IO/IM	not captured	standing	pages 57, 120

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	125 mL	IV/IO	not captured	standing	pages 51, 117
Hypoglycemia	peds	2 mL/kg	IV/IO	not captured	standing	pages 51, 117

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2 mg	IV/IM/SQ	not captured	standing	page 132
Seizure	adult	5 mg	IV/IO	not captured	standing	page 205
Seizure	peds	0.5 mg/kg	PR	not captured	standing	page 205

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	0.25 mg/kg	IV/IO	not captured	standing	page 23

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	PO	not captured	standing	pages 49, 115
Allergic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	pages 49, 115
Allergic reaction	peds	1 mg/kg	PO	not captured	standing	pages 49, 115
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	pages 49, 115

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 15
Hypotension / shock	adult	5–20 mcg/kg	IV/IO	not captured	standing	pages 56, 119
Hypotension / shock	peds	5–20 mcg/kg	IV/IO	not captured	standing	pages 56, 119

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	pages 49, 115
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 49, 115
Bradycardia	adult	1–10 mcg	IV/IO	not captured	standing	page 15
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	page 99
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 13, 29, 97, 108
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 13, 29, 97, 108
Croup	peds	1 mg	NEB	not captured	standing	pages 79, 85

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	page 77

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	peds	1 mcg/kg	IV/IO	not captured	standing	page 101
Mild to moderate pain	adult	50–100 mcg	IV/IO/IM	not captured	standing	page 201
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM	not captured	standing	page 201

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	40 mg	IV/IO	not captured	standing	pages 41, 101
CHF / pulmonary edema	peds	1 mg/kg	IV/IO	not captured	standing	pages 41, 101

G–L Glucagon, Haloperidol, Hydrocortisone, Hydromorphone, Ibuprofen, Imdevimab, Ipratropium, Ketamine, Ketorolac, Lidocaine, Lorazepam11

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2–4 mg	IV/IO/IM	not captured	standing	page 156
Beta-blocker / calcium-channel-blocker overdose	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 156
Hypoglycemia	adult	1–2 mg	IM	not captured	standing	pages 51, 117
Hypoglycemia	peds	0.1 mg/kg	IM	not captured	standing	pages 51, 117

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2–5 mg	IM	not captured	standing	page 215
Agitation	adult	2–5 mg	IM	not captured	standing	page 215
Agitation	adult	2 mg	IV/IM/SQ	not captured	standing	page 132

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	pages 57, 120
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 57, 120

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	0.5 mg	IV/IM/SQ	not captured	standing	page 132

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	400–600 mg	PO	not captured	standing	page 200
Fever	peds	10 mg/kg	PO	not captured	standing	page 200
Mild to moderate pain	adult	400–600 mg	PO	not captured	standing	page 201
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	page 201

Imdevimab

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	600 mg	IV	not captured	standing	page 134
Other	adult	600 mg	SQ	not captured	standing	page 134

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	0.5 mg	NEB	not captured	standing	pages 49, 115
Allergic reaction	peds	0.5 mg	NEB	not captured	standing	pages 49, 115
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 79, 85
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	pages 79, 85

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	4 mg/kg	IM	not captured	standing	pages 216, 217
Hyperactive delirium	peds	2 mg/kg	IM	not captured	standing	pages 216, 217
Mild to moderate pain	adult	0.3 mg/kg	IV/IO	not captured	standing	page 201
RSI induction	adult	1–2 mg/kg	IV/IO	not captured	standing	pages 77, 78
RSI induction	peds	1–2 mg/kg	IV/IO	not captured	standing	pages 77, 78

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	15 mg	IV/IO	not captured	standing	page 201
Severe pain	adult	30 mg	IM	not captured	standing	page 201
Severe pain	peds	0.5 mg/kg	IV/IO	not captured	standing	page 201
Severe pain	peds	0.5 mg/kg	IM	not captured	standing	page 201

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 29, 108
Cardiac arrest	peds	1–1.5 mg/kg	IV/IO	not captured	standing	pages 29, 108

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2 mg	IV/IM/SQ	not captured	standing	page 132
Seizure	adult	1–2 mg	IV/IO/IM	not captured	standing	page 205
Seizure	peds	0.05–0.1 mg/kg	IV/IO/IM	not captured	standing	page 205

M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nicardipine, Nitroglycerin, Norepinephrine, Ondansetron, Oxymetazoline10

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV/IO	not captured	standing	pages 79, 85
Asthma / bronchospasm	peds	40 mg/kg	IV/IO	not captured	standing	pages 79, 85
Cardiac arrest	adult	2 g	IV/IO	not captured	standing	pages 29, 108
Cardiac arrest	peds	2 g	IV/IO	not captured	standing	pages 29, 108
Narrow-complex tachycardia	adult	2 g	IV/IO	not captured	standing	pages 27, 28, 85, 108
Narrow-complex tachycardia	peds	40 mg/kg	IV/IO	not captured	standing	pages 27, 28, 85, 108

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	pages 57, 120
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 57, 120
Allergic reaction	adult	125 mg	IV/IO	not captured	standing	pages 49, 115
Allergic reaction	peds	2 mg/kg	IV/IO	not captured	standing	pages 49, 115
Asthma / bronchospasm	adult	125 mg	IV/IO/IM	not captured	standing	pages 79, 85
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	pages 79, 85

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5 mg	IV/IO/IN	not captured	standing	page 215
Agitation	adult	5 mg	IM	not captured	standing	page 215
Agitation	peds	0.1–0.2 mg/kg	IV/IO/IN	not captured	standing	page 215
Agitation	peds	0.1–0.2 mg/kg	IM	not captured	standing	page 215
Hyperactive delirium	adult	10 mg	IM	not captured	standing	page 216
Hyperactive delirium	peds	0.1–0.2 mg/kg	IM	not captured	standing	page 216
Procedural sedation	adult	2–2.5 mg	IV/IO/IM/IN	not captured	standing	page 15
Procedural sedation	adult	2–2.5 mg	IV/IO/IN	not captured	standing	pages 23, 25, 27, 104, 106
Procedural sedation	peds	0.1–0.2 mg/kg	IV/IO/IN	not captured	standing	pages 23, 25, 27, 104, 106
Seizure	adult	10 mg	IM	not captured	standing	page 205
Seizure	adult	2–2.5 mg	IV/IO	not captured	standing	page 205
Seizure	adult	5 mg	IN	not captured	standing	page 205
Seizure	peds	0.2 mg/kg	IV/IO	not captured	standing	page 205
Seizure	peds	0.2 mg/kg	IM	not captured	standing	page 205
Seizure	peds	0.2 mg/kg	IN	not captured	standing	page 205

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2–4 mg	IV/IO	not captured	standing	page 19
CHF / pulmonary edema	peds	0.1 mg/kg	IV/IO	not captured	standing	page 101
Mild to moderate pain	adult	2 mg	IV/IM/SQ	not captured	standing	page 132

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4–2 mg	IM/IN	not captured	standing	page 17
Opioid overdose	adult	0.4–2 mg	IV/IO/IM/IN/ET	not captured	standing	page 17
Opioid overdose	peds	0.1 mg/kg	IM/IN	not captured	standing	page 17
Opioid overdose	peds	0.1 mg/kg	IV/IO/IM/IN/ET	not captured	standing	page 17

Nicardipine

Indication	Population	Dose	Route	Repeat	Standing	Source
Stroke	adult	2.5 mg	IV	not captured	standing	page 58

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.3–0.4 mg	SL	not captured	standing	page 19
CHF / pulmonary edema	adult	0.3–0.4 mg	SL	not captured	standing	page 21

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	2–30 mcg	IV/IO	not captured	standing	pages 56, 57, 119
Hypotension / shock	peds	0.1–2 mcg/kg	IV/IO	not captured	standing	pages 56, 57, 119

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IO/IM/PO/ODT	not captured	standing	page 187
Nausea / vomiting	adult	4 mg	IV/IO/IM/PO/ODT	not captured	standing	page 187
Nausea / vomiting	peds	0.2 mg/kg	IV/IO/IM/PO/ODT	not captured	standing	page 187
Nausea / vomiting	peds	0.2 mg/kg	IV/IO/IM/PO/ODT	not captured	standing	page 187

Oxymetazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 spray	IN	not captured	standing	pages 49, 115, 198
Other	peds	2 spray	IN	not captured	standing	pages 49, 115, 198

P–R Pralidoxime, Promethazine, Rocuronium3

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	pages 158, 159

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	25 mg	IV/IM	not captured	standing	page 132

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1 mg/kg	IV/IO	not captured	standing	page 77

S–Z Sodium Bicarbonate, Tranexamic Acid, Vecuronium3

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	50 mEq	IV/IO	not captured	standing	pages 53, 167
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 53, 167
Tricyclic overdose	adult	50 mEq	IV/IO	not captured	standing	page 156
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	page 156

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	1–2 g	IV/IO	not captured	standing	pages 69, 172
Trauma / hemorrhage	adult	1–2 g	IV/IO	not captured	standing	pages 69, 172
Trauma / hemorrhage	adult	10 mL	TOP	not captured	standing	pages 195, 196

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	IV/IO	not captured	standing	page 87

Haywood County EMS System

Drugs and doses47